Back to searchResult Papers0
Derived Papers0
Unknown Papers7
Investigation of Naltrexone for Pathological Gambling
NCT01057862
PHASE2INTERVENTIONAL
Yale University
9 participants
Started 2009-02 · Completed 2017-01
Status: Completed (as of 12-23-2025)
Conditions
Pathological Gambling
Interventions
Linked Papers (from SciSciNet-V2)
Total Papers8
Background
1Result
0Derived
0Unknown
7Total Citations Per Year
Brief Summary
The investigators plan to investigate the safety, tolerability, and efficacy of the opioid antagonist naltrexone in Pathological Gambling. We hypothesize that naltrexone will be superior to placebo in reducing gambling urges and behavior, when combined with adjuvant non-pharmacological treatment as usual.
Sort by:
Result Papers0
No result papers linked
Derived Papers0
No derived papers linked
Unknown Papers7
Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling
2001
476 citations
Multicenter Investigation of the Opioid Antagonist Nalmefene in the Treatment of Pathological Gambling
2006
346 citations
Outcome of psychological treatments of pathological gambling: a review and meta‐analysis
2005
261 citations
A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist Naltrexone in the Treatment of Pathological Gambling Urges
2008
241 citations
Psychological treatment dropout among pathological gamblers
2007
128 citations
An open naltrexone treatment study in pathological gambling disorder
2001
127 citations
Outcome of Pharmacological Treatments of Pathological Gambling
2007
124 citations